Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C/IV ovarian cancer. Is there any difference?

To compare the results of the administration of HIPEC with Paclitaxel or Cisplatin after cytoreduction in patients with stage IIIC-IV ovarian cancer, especially focused on disease-free survival.

Source: Surgical Oncology - May 19, 2016 Category: Surgery Authors: P. Cascales-Campos, V. López-López, Gil J, J. Arévalo-Pérez, A. Nieto, F. Barceló, E. Gil, P. Parrilla Source Type: research